FDA Warns Sanofi of Manufacturing Irregularities at Key Facility
2025-01-23
Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicinesContinue Reading
-690x550.jpg)
Controlling Infections Might Lower Dementia Risk
2025-01-23
THURSDAY, Jan. 23, 2025 (HealthDay News) — Preventing or treating infections could be a key means of warding off dementia, a new evidence review says. Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Jan. 21 inContinue Reading
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
2025-01-22
Drug is the first and only approved monotherapy for refractory major depressive disorderContinue Reading
Trump Ends Push To Slash Prescription Drug Costs
2025-01-22
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid. Trump’s order, signed shortly after his inauguration on Monday, targets policies his administrations calls “deeplyContinue Reading
Moderna Receives $590M From HHS To Develop Bird Flu Vaccine
2025-01-21
TUESDAY, Jan. 21, 2025 (HealthDay News) — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This funding, announced Friday by Moderna, builds on the $176 million it received from HHS lastContinue Reading
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
2025-01-21
TUESDAY, Jan. 21, 2025 (HealthDay News) — Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia. But these drugs also come with risks that shouldn’t be overlooked, researchers warn in a study publishedContinue Reading
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
2025-01-16
Approval based on results from phase 3 VIVID-1 trial, in which end points of clinical remission and endoscopic response were met at one yearContinue Reading
Let’s Address Tomorrow’s Antivax Arguments Today: Pediatrics Expert
2025-01-08
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — Public health officials must prepare to counter ongoing anti-vaccine sentiment in coming years, argues a leading pediatrician-scientist. “Antivaccine activism became a major lethal force in America” during the COVID-19 pandemic, resulting in an estimated 200,000 deaths among the unvaccinated, according to an articleContinue Reading
Blood Test May Help Predict How Long Immunity Lasts
2025-01-07
TUESDAY, Jan. 7, 2024 (HealthDay News) — It’s long been a mystery why folks need a flu vaccine every year, even though immunizations they got in childhood continue to protect them from measles and mumps. Researchers now think they know why vaccine effectiveness varies — and they’ve even come upContinue Reading
U.S. Whooping Cough Cases Surge
2025-01-06
MONDAY, Jan. 6, 2025 (HealthDay News) — Rates of whooping cough in the U.S. continue to climb, according to data from the US Centers for Disease Control (CDC). Over 32,000 cases reported have been reported as of mid-December — about six times more than there were at this time lastContinue Reading